Literature DB >> 23837221

The role of inflammation and endothelial dysfunction in the pathogenesis of diabetic retinopathy.

Martina Tomić1, Spomenka Ljubić, Snjezana Kastelan.   

Abstract

The pathogenesis of diabetic retinopathy (DR) is insufficiently understood and presumed to possibly involve inflammation and endothelial dysfunction. The aim of the study was to investigate the relationship between inflammation markers, other markers of endothelial dysfunction and anthropometric parameters and their association with DR in patients with type 2 diabetes, divided into three groups: no retinopathy (N = 65), mild/moderate nonproliferative diabetic retinopathy (NPDR; N = 19) and severe NPDR/proliferative diabetic retinopathy (PDR; N = 23). The groups did not differ in the levels of inflammation markers, other markers of endothelial dysfunction and anthropometric parameters. C-reactive protein was correlated with fibrinogen, HbA1c, LDL-cholesterol, BMI, WC, WHR and C index. HbA1c was correlated with cholesterol, LDL-cholesterol, BMI and WC. Logistic regression analysis showed that diabetes duration and HbAlc median were the main predictors of retinopathy. The study demonstrated that the association between obesity, inflammation and other risk factors plays an important role in endothelial impairment involved in the pathogenesis of DR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23837221

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  20 in total

1.  Increased interleukin-26 expression in proliferative diabetic retinopathy.

Authors:  Peng Wang; Wen-Yan Wang; Xue-Dong Zhang
Journal:  Int J Ophthalmol       Date:  2019-11-18       Impact factor: 1.779

2.  Effect of the blockade of the IL-23-Th17-IL-17A pathway on streptozotocin-induced diabetic retinopathy in rats.

Authors:  Haiyan Xu; Min Cai; Xuedong Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-05       Impact factor: 3.117

3.  Higher prevalence of diabetic retinopathy among female Chinese diabetic patients with metabolic syndrome.

Authors:  Zhong Lin; Yu Wang; Dong Li; Liang Wen; Gang Zhai; Xiao Xia Ding; Dong Xiao Zang; Feng Hua Wang; Yuan Bo Liang
Journal:  Jpn J Ophthalmol       Date:  2021-10-16       Impact factor: 2.447

4.  Long noncoding RNA PVT1 regulates the proliferation and apoptosis of ARPE-19 cells in vitro via the miR-1301-3p/KLF7 axis.

Authors:  Jianjin Guo; Yuan Chen; Jiajia Xu; Liqi Li; Wenjiao Dang; Feng Xiao; Wei Ren; Yikun Zhu; Qiujing Du; Qian Li; Xing Li
Journal:  Cell Cycle       Date:  2022-04-22       Impact factor: 5.173

5.  C-reactive protein and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus.

Authors:  Xiu-Fen Yang; Yu Deng; Hong Gu; Apiradee Lim; Torkel Snellingen; Xi-Pu Liu; Ning-Li Wang; Amitha Domalpally; Ronald Danis; Ning-Pu Liu
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

6.  Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy.

Authors:  Roxanne Crosby-Nwaobi; Irini Chatziralli; Theodoros Sergentanis; Tracy Dew; Angus Forbes; Sobha Sivaprasad
Journal:  J Diabetes Res       Date:  2015-07-29       Impact factor: 4.011

7.  Obesity and diabetic retinopathy: What is the association?

Authors:  Behzad Heidari
Journal:  Caspian J Intern Med       Date:  2015

Review 8.  Inflammation and pharmacological treatment in diabetic retinopathy.

Authors:  Snježana Kaštelan; Martina Tomić; Antonela Gverović Antunica; Jasminka Salopek Rabatić; Spomenka Ljubić
Journal:  Mediators Inflamm       Date:  2013-10-28       Impact factor: 4.711

9.  Body mass index and retinopathy in type 1 diabetic patients.

Authors:  Snježana Kaštelan; Jasminka Salopek Rabatić; Martina Tomić; Antonela Gverović Antunica; Spomenka Ljubić; Helena Kaštelan; Branko Novak; Darko Orešković
Journal:  Int J Endocrinol       Date:  2014-02-18       Impact factor: 3.257

10.  Body mass index: a risk factor for retinopathy in type 2 diabetic patients.

Authors:  Snježana Kaštelan; Martina Tomić; Antonela Gverović Antunica; Spomenka Ljubić; Jasminka Salopek Rabatić; Mirela Karabatić
Journal:  Mediators Inflamm       Date:  2013-11-20       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.